Recombinant Enterobacteria phage P2 Holin (Y)

Shipped with Ice Packs
In Stock

Description

Molecular Characterization of Recombinant Enterobacteria Phage P2 Holin (Y)

Recombinant Holin (Y) is a 93-amino acid protein expressed in Escherichia coli with an N-terminal His tag for purification. Key features include:

PropertyDetail
UniProt IDP51773
Gene NameY
Protein LengthFull-length (1-93 aa)
Molecular FunctionClass I holin with 3 transmembrane domains (TMDs) and a charged C-terminal
Expression SystemE. coli
TagHexahistidine (His-tag)
Purity>90% (SDS-PAGE)
StorageLyophilized powder in Tris/PBS buffer with 6% trehalose (pH 8.0)

Key Functional Domains

DomainFeatureRole
Transmembrane 1–3Hydrophobic α-helical regionsMembrane insertion and pore formation
C-terminal tailPositively charged cytoplasmic regionInteraction with endolysin/LysA

Comparative Analysis with Lambda Holin (S105)

Studies highlight functional parallels and divergences between P2 Y and lambda S105 holins :

FeatureP2 Holin (Y)Lambda Holin (S105)
TopologyN-out, C-in with 3 TMDsN-out, C-in with 3 TMDs
Antiholin SystemLysA (external protein)S107 (embedded in holin gene)
C-terminal DomainEssential for functionDispensable
Lysis Timing RegulationRequires LysAIntrinsic S105/S107 ratio

Production and Purification Protocol

Recombinant Holin (Y) is generated via the following steps :

  1. Cloning: Full-length Y gene insertion into an E. coli expression vector.

  2. Expression: Induced under optimized conditions for soluble protein yield.

  3. Purification: Affinity chromatography using Ni-NTA resin (His-tag).

  4. Formulation: Lyophilization with trehalose for stability.

Critical Notes for Handling

  • Avoid repeated freeze-thaw cycles; aliquot for long-term storage (-80°C).

  • Reconstitute in deionized water (0.1–1.0 mg/mL) with 50% glycerol for experiments.

5.1. Lysis Mechanism Studies

  • Allele-Specific Lethality: Frameshift mutations in Y delay lysis, resolvable via chloroform-induced membrane disruption .

  • Membrane Dynamics: Y’s pore formation is inhibited by proton motive force collapse, underscoring energy dependence .

5.2. Antibacterial Agent Development

  • Synergy with Endolysins: Holin-endolysin pairs are being explored as precision antimicrobials .

  • LysA Antiholin Studies: Insights into delaying lysis could optimize phage therapy timing .

Challenges and Future Directions

  • Structural Resolution: No crystal structure exists; cryo-EM studies are needed to map pore assembly.

  • Evolutionary Insights: Horizontal gene transfer of Y-like holins among phages (e.g., P1, Mu, λ) suggests shared lysis strategies .

Product Specs

Form
Lyophilized powder
Note: We will prioritize shipping the format currently in stock. However, if you have a specific format preference, please indicate your requirement when placing the order, and we will fulfill your request.
Lead Time
Delivery time may vary depending on the purchasing method and location. Please consult your local distributors for specific delivery timeframes.
Note: All of our proteins are shipped with standard blue ice packs. If you require dry ice shipping, please inform us in advance, as additional fees will apply.
Notes
Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.
Reconstitution
We recommend centrifuging the vial briefly prior to opening to ensure the contents are at the bottom. Please reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard final glycerol concentration is 50%, which can be used as a reference.
Shelf Life
The shelf life is influenced by various factors, including storage conditions, buffer components, storage temperature, and the inherent stability of the protein.
Generally, the shelf life of the liquid form is 6 months at -20°C/-80°C. The shelf life of the lyophilized form is 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquoting is recommended for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type will be determined during the manufacturing process.
If you have a specific tag type requirement, please inform us, and we will prioritize the development of your specified tag.
Synonyms
Y; Holin
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-93
Protein Length
full length protein
Species
Escherichia phage P2 (Bacteriophage P2)
Target Names
Y
Target Protein Sequence
MTAEEKSVLSLFMIGVLIVVGKVLAGGEPITPRLFIGRMLLGGFVSMVAGVVLVQFPDLS LPAVCGIGSMLGIAGYQVIEIAIQRRFKGRGKQ
Uniprot No.

Target Background

Function
This protein accumulates harmlessly in the cytoplasmic membrane until it reaches a critical concentration. This triggers the formation of micron-scale pores (holes) causing host cell membrane disruption and endolysin escape into the periplasmic space (Probable). It plays a crucial role in determining the precise timing of host cell lysis (Probable). This protein, along with the endolysin and spanin proteins, participates in the sequential events that lead to the programmed host cell lysis, releasing mature viral particles from the host cell (Probable).
Database Links

KEGG: vg:1261546

Protein Families
P2likevirus holin family
Subcellular Location
Host cell inner membrane; Multi-pass membrane protein.

Q&A

What is the fundamental role of P2 Holin (Y) in the phage lytic cycle?

P2 Holin (Y) belongs to the class I holins that play a critical role in the timed lysis of bacterial hosts during the phage infection cycle. The holin functions by creating holes in the cytoplasmic membrane at a genetically programmed time, allowing the endolysin enzyme to access the peptidoglycan layer. This coordinated action ultimately leads to cell lysis and release of phage progeny .

Unlike endolysins that directly attack the peptidoglycan, holins cause saltatory lethal membrane permeabilization. When holins reach a critical concentration in the membrane, they undergo a conformational change that leads to the formation of lesions, causing the membrane to lose its ability to support respiration and membrane potential. This allows the release of endolysins from the cytoplasm to the periplasmic space where they can access their peptidoglycan substrate .

How does the structure of P2 Holin (Y) relate to its function?

P2 Holin (Y) is a relatively small membrane protein with transmembrane domains that allow it to insert into the cytoplasmic membrane. While specific structural details of P2 Holin (Y) are not extensively characterized, class I holins generally contain three transmembrane domains with the N-terminus in the periplasm and the C-terminus in the cytoplasm .

The structure-function relationship in holins is critically linked to their ability to oligomerize within the membrane. At a genetically determined time, these oligomers assemble into higher-order structures that disrupt membrane integrity. This structural transition is the molecular basis for the precise timing mechanism that coordinates the lysis event with the completion of virion assembly .

How does P2 Holin (Y) differ from holins in other phage systems?

P2 Holin (Y) belongs to a diverse superfamily of holin proteins that show remarkable variability despite similar functions. There are approximately 150 holin genes identified across phage genomes, defining more than 35 unrelated orthologous gene families .

While P2 Holin (Y) is classified as a class I holin (containing three transmembrane domains), other phages may utilize class II holins (with two transmembrane domains) or class III holins (with one transmembrane domain). This diversity reflects the convergent evolution of lysis timing mechanisms across different phage lineages .

Despite this diversity in primary sequence and membrane topology, all holins share the common functional property of precisely timed membrane disruption. This timing is essential for optimizing phage reproduction, as premature lysis would reduce viral yield while delayed lysis would waste cellular resources once virion assembly is complete .

What are the most effective methods for expressing recombinant P2 Holin (Y) in E. coli?

Expressing functional P2 Holin (Y) presents challenges due to its toxic nature when overexpressed. A controlled expression system is essential, typically using inducible promoters such as arabinose-inducible pBAD systems. This allows for tight regulation of expression levels to prevent premature toxicity .

The methodological approach typically involves:

  • Cloning the holin gene into a vector with a tightly regulated promoter

  • Transforming the construct into E. coli strains optimized for membrane protein expression

  • Growing cultures to an appropriate density (OD600 ~0.5) before induction

  • Using low inducer concentrations to maintain viability while achieving sufficient expression

  • Harvesting cells quickly after induction, before significant lysis occurs

Additionally, co-expression with its cognate antiholin can help modulate toxicity and improve yields. For membrane protein purification, detergent screening is critical to identify conditions that maintain the native conformation of the holin protein .

How can researchers accurately assess the lytic activity of recombinant P2 Holin (Y)?

Assessing P2 Holin (Y) lytic activity requires multi-parameter measurement approaches:

  • Growth curve analysis: Monitoring bacterial density (OD600) after holin induction to track lysis kinetics. A sharp decrease in OD600 indicates the triggering of the lytic event.

  • Membrane potential measurements: Using potential-sensitive dyes (like DiBAC4) to detect the membrane depolarization that precedes lysis.

  • ATP release assays: Measuring extracellular ATP as an indicator of membrane permeabilization.

  • Electron microscopy: Examining cell morphology before and after holin triggering to visualize membrane lesions.

  • Complementation assays: Testing the ability of the recombinant holin to complement lysis-defective phage mutants.

For precise quantification, researchers should normalize lytic activity to protein expression levels, as determined by Western blotting with anti-Holin antibodies. The timing of lysis relative to induction is a critical parameter that reflects holin functionality .

What mutagenesis approaches are most informative for studying P2 Holin (Y) function?

Mutagenesis studies of P2 Holin (Y) provide crucial insights into structure-function relationships. The most informative approaches include:

  • Alanine-scanning mutagenesis: Systematically replacing residues with alanine to identify those critical for function, particularly within transmembrane domains.

  • Charge substitutions: Introducing charged residues within transmembrane regions to disrupt membrane insertion or oligomerization.

  • Domain swapping: Exchanging domains between different holins to identify regions responsible for timing and specificity.

  • Nonsense-to-sense mutations: Similar to those used in the P2 spike protein studies, these can be adapted to study holin function by generating amber mutations that can be suppressed in specific strains .

For experimental implementation, the λ red recombinase system has proven effective for phage genome mutagenesis, as demonstrated in studies of P2 baseplate components . After mutagenesis, phenotypic characterization should include lysis timing assays, complementation tests, and protein localization studies to comprehensively assess the impact of mutations on holin function.

How can P2 Holin (Y) be engineered for controlled lysis in biotechnological applications?

Engineering P2 Holin (Y) for biotechnological applications focuses on creating tunable lysis systems with precise temporal control:

  • Promoter engineering: Replacing the native promoter with inducible systems allows external control of lysis timing. This can be achieved using arabinose, IPTG, or tetracycline-responsive elements with varying strengths.

  • Dual-control systems: Combining transcriptional and post-translational control by engineering both the promoter and the holin-antiholin interaction interface.

  • Temperature-sensitive variants: Creating mutants that trigger at specific temperatures through targeted mutations in the transmembrane domains.

  • Chimeric holins: Similar to the tail fiber engineering approach described for phage P2, the holin can be modified by domain swapping with other holins to alter its properties .

The engineered systems should be validated using quantitative lysis assays and microscopy-based single-cell analysis to confirm homogeneity of lysis timing across the population. Applications include controlled release of recombinant proteins, timed delivery of therapeutic payloads, and development of self-destructing bacterial vectors for environmental containment .

What approaches can be used to modify the timing of P2 Holin (Y)-mediated lysis?

Modifying the timing of P2 Holin (Y)-mediated lysis requires interventions at multiple levels:

  • Protein engineering approaches:

    • Point mutations in the transmembrane domains can alter oligomerization kinetics

    • Modifications to charged residues can affect protein stability and triggering threshold

    • Alterations to the N-terminal domain can modify interactions with the antiholin

  • Expression-level control:

    • Adjusting gene copy number through plasmid design

    • Modifying the strength of ribosome binding sites

    • Using degradation tags to control protein turnover rates

  • Environmental triggers:

    • Engineering voltage-sensitive variants that respond to membrane potential changes

    • Creating pH-responsive variants through histidine substitutions in critical domains

Each modification should be quantitatively assessed using time-lapse microscopy to measure the distribution of lysis times in individual cells. The goal is to achieve predictable, reproducible timing with minimal cell-to-cell variation, which is essential for synchronized lysis applications .

How can P2 Holin (Y) be integrated with non-native endolysins for targeted bacterial control?

Integrating P2 Holin (Y) with non-native endolysins creates customizable lysis systems for targeted bacterial control:

  • Endolysin selection criteria:

    • Choose endolysins with complementary activity spectra to target specific bacterial species

    • Consider the peptidoglycan type of the target bacteria (Gram-positive vs. Gram-negative)

    • Evaluate stability and activity under the desired application conditions

  • Expression optimization:

    • Design polycistronic constructs with optimized translation efficiency for both genes

    • Consider separate inducible promoters for independent control of holin and endolysin levels

    • Test various gene arrangements to minimize interference between expression units

  • Delivery system design:

    • Engineer phage particles as delivery vehicles using recombination approaches

    • Adapt the P2 cosmid packaging system used in host range expansion studies

    • Consider encapsulation in liposomes for non-phage delivery applications

Validation of these hybrid systems should include specificity testing across a panel of bacterial species, quantification of killing efficiency, and assessment of resistance development rates. This approach parallels the successful retargeting of P2 phage particles toward new bacterial hosts through tail fiber engineering, but focuses on the lysis mechanism rather than host recognition .

What are the common challenges in purifying functional P2 Holin (Y) and how can they be overcome?

Purifying functional P2 Holin (Y) presents several challenges due to its membrane-associated nature and potential toxicity:

  • Protein toxicity issues:

    • Challenge: Expression often leads to premature cell lysis or growth inhibition

    • Solution: Use tight expression control with leak-free promoters and optimize induction time

    • Implementation: Arabinose-inducible systems with glucose repression can minimize leaky expression

  • Membrane protein solubilization:

    • Challenge: Efficient extraction from membranes without denaturation

    • Solution: Screen multiple detergents (DDM, LDAO, C12E8) in combination with stabilizing agents

    • Implementation: Initially extract with mild detergents at low temperatures (4°C)

  • Maintaining native conformation:

    • Challenge: Holins tend to form non-native aggregates during purification

    • Solution: Include lipids during purification and consider fusion tags that enhance stability

    • Implementation: Add E. coli polar lipid extract during solubilization and purification steps

  • Functional validation:

    • Challenge: Determining if purified holin retains native activity

    • Solution: Develop liposome-based dye release assays to test pore formation activity

    • Implementation: Reconstitute purified protein in liposomes loaded with fluorescent dyes

The purification protocol should incorporate elements from successful membrane protein purification techniques, adapted to the specific properties of class I holins like P2 Holin (Y) .

How can researchers troubleshoot issues with inconsistent lysis timing in P2 Holin (Y) experiments?

Inconsistent lysis timing in P2 Holin (Y) experiments can significantly impact reproducibility. This challenge can be addressed systematically:

  • Expression level variability:

    • Cause: Inconsistent induction or plasmid copy number variations

    • Diagnosis: Quantify protein levels via Western blot at multiple time points

    • Solution: Standardize culture conditions (temperature, media composition, aeration) and use single-copy integration instead of plasmids

  • Physiological state differences:

    • Cause: Variations in growth phase or metabolic state affect timing

    • Diagnosis: Monitor growth curves and correlate with lysis timing

    • Solution: Strictly control starting OD and growth conditions; consider using chemostat cultures

  • Membrane composition effects:

    • Cause: Variations in phospholipid content affect holin insertion and triggering

    • Diagnosis: Analyze membrane composition in consistent vs. inconsistent batches

    • Solution: Use defined media to control lipid precursor availability

  • Antiholin interference:

    • Cause: Variable expression of native antiholins

    • Diagnosis: Genetic analysis for antiholin-encoding prophages in the host

    • Solution: Use strains cured of prophages or knock out known antiholin genes

For methodological implementation, researchers should adopt a standardized protocol similar to those used in P2 phage propagation studies, with precise control of temperature, media composition, and timing of manipulations .

What factors affect the host range when using P2 Holin (Y) in heterologous systems?

When adapting P2 Holin (Y) for use in heterologous systems, several factors influence functionality across different bacterial hosts:

  • Membrane composition differences:

    • Impact: Phospholipid composition affects holin insertion, oligomerization, and pore formation

    • Assessment: Compare lysis efficiency in hosts with characterized membrane differences

    • Adaptation: Pre-screen host strains for compatibility or engineer holins with broader lipid tolerance

  • Protein processing variations:

    • Impact: Differences in membrane insertion machinery may affect holin folding

    • Assessment: Analyze protein localization using fluorescent fusions

    • Adaptation: Include species-specific signal sequences if necessary

  • Regulatory compatibility:

    • Impact: Promoter recognition and translation efficiency vary between hosts

    • Assessment: Measure expression levels using reporter gene fusions

    • Adaptation: Use broad-host-range expression systems or host-specific regulatory elements

  • Interaction with native lysis inhibitors:

    • Impact: Endogenous antiholins may interfere with the recombinant holin

    • Assessment: Test in wild-type vs. antiholin-deficient strains

    • Adaptation: Engineer holin variants resistant to host antiholins

This approach to host range extension is conceptually similar to how P2 phage particles have been retargeted to different bacterial hosts through tail fiber engineering, but focuses specifically on optimizing the lysis system for diverse cellular environments .

How does P2 Holin (Y) compare with other class I holins in terms of lysis efficiency and timing control?

P2 Holin (Y) shares fundamental characteristics with other class I holins but exhibits distinct properties that influence its application in research contexts:

FeatureP2 Holin (Y)T4 Holin (T)λ Holin (S)
Transmembrane domains333
Timing precisionHighModerateVery high
Antiholin regulationPresentComplexWell-characterized
Oligomerization kineticsRapidGradualThreshold-dependent
Membrane specificityE. coli-optimizedBroadE. coli-optimized
Lysis completenessNearly completeVariableNearly complete

P2 Holin (Y) demonstrates excellent timing precision, which is critical for synchronizing lysis with virion assembly. This timing mechanism involves a delicate balance between holin accumulation in the membrane and the triggering threshold for pore formation. The P2 system appears to have evolved for rapid and nearly complete lysis, reflecting its adaptation to the enterobacterial infection cycle .

What are the key differences in experimental approaches for studying P2 Holin (Y) versus phage P2 tail proteins?

The experimental approaches for studying P2 Holin (Y) versus phage P2 tail proteins differ significantly due to their distinct roles and properties:

AspectP2 Holin (Y) ApproachesP2 Tail Protein Approaches
Expression systemsTightly regulated inducible systems to prevent toxicityStandard expression systems with less stringent regulation
Purification strategyMembrane protein extraction with detergentsAqueous extraction or inclusion body refolding
Functional assaysLysis timing, membrane permeabilizationHost binding, adsorption assays
Mutagenesis targetsTransmembrane domains, oligomerization interfacesReceptor-binding domains, assembly interfaces
Interaction partnersEndolysins, antiholinsBaseplate components, host receptors
Visualization methodsMembrane protein localization techniquesElectron microscopy of assembled structures

While tail protein studies (like those focusing on gpH and gpV) emphasize host range expansion through receptor specificity , holin research focuses on the precisely timed triggering of membrane permeabilization. The methodologies diverge accordingly, with tail protein studies utilizing techniques like phage pulldown assays and receptor binding studies, while holin research requires membrane-focused approaches including fluorescent membrane potential indicators and liposome reconstitution .

For researchers transitioning between these areas, it's essential to adapt experimental approaches to account for these fundamental differences in protein properties and function.

How do the engineering principles for P2 Holin (Y) modification differ from those used in P2 tail fiber engineering?

The engineering principles for P2 Holin (Y) modification differ substantially from those used in P2 tail fiber engineering, reflecting their distinct functions in the phage life cycle:

Engineering AspectP2 Holin (Y) ModificationP2 Tail Fiber Engineering
Primary goalPrecise timing of lysisHost range extension
Critical domainsTransmembrane segments affecting oligomerizationReceptor-binding regions determining host specificity
Design approachPoint mutations and small modificationsDomain swapping and chimeric constructs
Functional constraintsMust maintain membrane insertion and pore formationMust maintain structural compatibility with baseplate
Validation metricsLysis timing, efficiency, and membrane permeabilizationHost adsorption, infection efficiency across strains
Evolutionary considerationsHighly conserved function with sequence diversityRapidly evolving to adapt to new hosts

Tail fiber engineering, as demonstrated in studies with HomA-PK2 and Lit2C-PK2 chimeras, focuses on extending phage host range by modifying receptor specificity while maintaining structural compatibility with the phage baseplate . This approach often utilizes domain swapping between phages with different host specificities.

In contrast, P2 Holin (Y) engineering focuses on the timing and efficiency of the lysis event. Rather than wholesale domain exchanges, subtle modifications that affect protein stability, membrane insertion, or oligomerization kinetics are more effective. The goal is not to change target specificity (as the membrane is a universal target) but rather to optimize the temporal control of lysis .

Both engineering approaches require careful consideration of protein structure-function relationships, but they diverge in their implementation due to the distinct roles these proteins play in the phage infection cycle.

What emerging technologies could advance our understanding of P2 Holin (Y) structure and function?

Several emerging technologies have the potential to significantly advance our understanding of P2 Holin (Y):

  • Cryo-electron microscopy for membrane proteins:

    • Application: Determining the structure of P2 Holin (Y) in native-like lipid environments

    • Advantage: Reveals oligomeric arrangements and pore formation mechanisms

    • Implementation: Using nanodiscs or lipid nanodiscs to stabilize holin complexes for imaging

  • Single-molecule fluorescence techniques:

    • Application: Tracking holin diffusion, clustering, and pore formation in real-time

    • Advantage: Provides dynamic information not accessible through static structural methods

    • Implementation: Using fluorescently labeled holins in supported lipid bilayers or live cells

  • Advanced molecular dynamics simulations:

    • Application: Modeling holin-membrane interactions and conformational changes

    • Advantage: Provides atomic-level insights into triggering mechanisms

    • Implementation: Combining experimental structural data with computational modeling

  • High-throughput mutagenesis and phenotyping:

    • Application: Comprehensive mutational scanning of the entire holin sequence

    • Advantage: Identifies all residues critical for function and timing

    • Implementation: CRISPR-based approaches for in vivo mutation libraries

These advanced technologies could help resolve key questions about holin function that have remained challenging to address with traditional techniques, such as the precise molecular trigger for hole formation and the detailed structure of membrane pores .

How might synthetic biology approaches incorporate P2 Holin (Y) into novel antimicrobial strategies?

Synthetic biology offers exciting opportunities to incorporate P2 Holin (Y) into next-generation antimicrobial strategies:

  • Engineered phage therapy platforms:

    • Concept: Combining tailored host recognition (via engineered tail fibers) with optimized lysis timing

    • Implementation: Similar to the approaches used for P2 retargeting toward Salmonella , but with enhanced lysis modules

    • Advantage: Precisely timed lysis optimizes therapeutic efficacy by balancing phage amplification with bacterial killing

  • Bacteria-triggered lysis systems:

    • Concept: Creating bacterial sensors that activate holin expression in response to pathogen detection

    • Implementation: Linking P2 Holin (Y) expression to quorum sensing or virulence factor detection systems

    • Advantage: Provides spatial and temporal control of antimicrobial activity

  • Genetic circuit-controlled lysis devices:

    • Concept: Designing genetic circuits that trigger holin-mediated lysis based on complex input logic

    • Implementation: Using synthetic transcriptional and post-translational regulation of holin expression

    • Advantage: Allows for sophisticated decision-making before committing to lysis

  • Membrane-targeting nanomedicines:

    • Concept: Using holin-inspired peptides as membrane-disrupting therapeutic agents

    • Implementation: Identifying the minimal functional units of P2 Holin (Y) for synthetic peptide design

    • Advantage: Potential to overcome antibiotic resistance mechanisms

These approaches build upon the demonstrated capacity to engineer P2 phage for retargeting toward pathogenic bacterial strains, as shown in studies with Salmonella , but with additional focus on optimizing the lysis mechanism for therapeutic applications.

What are the potential applications of combining P2 Holin (Y) engineering with CRISPR-Cas systems for bacterial control?

The integration of P2 Holin (Y) engineering with CRISPR-Cas systems creates powerful new approaches for precision bacterial control:

  • Programmable bacterial elimination systems:

    • Concept: CRISPR-Cas identifies specific bacterial genotypes, triggering holin-mediated lysis

    • Implementation: Linking Cas protein activity to holin expression through genetic circuits

    • Application: Selective removal of antibiotic-resistant bacteria from mixed populations

  • Self-limiting genetic delivery vehicles:

    • Concept: Phage particles deliver CRISPR payloads, followed by timed holin-mediated lysis

    • Implementation: Adapting the P2 cosmid packaging system used for host range expansion

    • Application: Delivery of genome editing tools with controlled persistence

  • Microbiome editing platforms:

    • Concept: Combined CRISPR targeting and holin-mediated lysis for species-specific microbiome modification

    • Implementation: Engineered phage vectors with tailored host range and optimized lysis timing

    • Application: Removal of specific pathogenic species while preserving beneficial microbiota

  • Containment systems for engineered bacteria:

    • Concept: CRISPR-responsive kill switches using holins for efficient elimination

    • Implementation: Environmental sensors linked to Cas protein activation and subsequent holin expression

    • Application: Biocontainment of genetically modified organisms

The technical implementation would build upon demonstrated approaches for P2 phage engineering , combining them with the specificity of CRISPR-Cas systems. This would require optimizing the coordination between CRISPR recognition events and the timing of holin-mediated lysis, potentially through sophisticated genetic circuits with appropriate sensing and amplification components.

What quality control measures are essential when working with recombinant P2 Holin (Y)?

  • Expression verification:

    • Method: Western blotting with anti-His or specific anti-Holin antibodies

    • Critical parameters: Confirm correct molecular weight and absence of degradation products

    • Frequency: For each new expression batch before functional testing

  • Membrane localization assessment:

    • Method: Subcellular fractionation followed by immunoblotting

    • Critical parameters: Enrichment in membrane fractions versus cytoplasmic contamination

    • Frequency: When establishing new constructs or expression systems

  • Functional activity testing:

    • Method: Standardized lysis assays measuring OD600 decline rate

    • Critical parameters: Consistent triggering time and lysis completion

    • Frequency: For every preparation used in experiments

  • Protein-lipid ratio determination:

    • Method: Phospholipid assays combined with protein quantification

    • Critical parameters: Consistent protein-to-lipid ratios in membrane preparations

    • Frequency: For preparations used in detailed mechanistic studies

  • Oligomeric state analysis:

    • Method: Blue native PAGE or size exclusion chromatography

    • Critical parameters: Distribution of monomeric versus oligomeric species

    • Frequency: When investigating structure-function relationships

These quality control measures should be systematically implemented in a workflow similar to those used for purification and characterization of phage structural components , with appropriate modifications for membrane protein analysis.

How should researchers optimize P2 Holin (Y) expression conditions to balance yield and functionality?

Optimizing P2 Holin (Y) expression requires balancing protein yield with functional integrity:

  • Expression temperature optimization:

    • Strategy: Test expression at 18°C, 25°C, and 30°C with extended induction times

    • Measurement: Compare yields and lytic activity at each temperature

    • Typical finding: Lower temperatures (18-25°C) often improve folding of membrane proteins

    • Implementation: Use temperature-controlled shakers with precise monitoring

  • Inducer concentration titration:

    • Strategy: Test a range of inducer concentrations (0.01-0.2% arabinose or 0.01-1mM IPTG)

    • Measurement: Quantify protein yield and lytic activity at each concentration

    • Typical finding: Lower inducer concentrations often improve folding while reducing toxicity

    • Implementation: Prepare fresh inducer stocks for each experiment to ensure consistency

  • Host strain selection:

    • Strategy: Compare expression in BL21(DE3), C41(DE3), C43(DE3), and Lemo21(DE3)

    • Measurement: Assess growth curves, final yields, and functionality

    • Typical finding: C41/C43 strains often better tolerate membrane protein expression

    • Implementation: Maintain consistent growth media and conditions across strain comparisons

  • Membrane-enhancing supplements:

    • Strategy: Test addition of glycerol (5-10%) or specific phospholipids to growth media

    • Measurement: Compare membrane incorporation efficiency and function

    • Typical finding: Glycerol can stabilize membrane proteins during expression

    • Implementation: Add supplements at culture initiation before induction

These optimization approaches should be implemented systematically, using experimental designs that allow statistical analysis of results. The optimal conditions are likely to differ somewhat from those used for phage structural proteins due to the membrane-associated nature of holins .

What are the best approaches for developing accurate computational models of P2 Holin (Y) function?

Developing accurate computational models of P2 Holin (Y) function requires integrating structural predictions with dynamic simulations:

  • Transmembrane topology prediction:

    • Approach: Combine multiple prediction algorithms (TMHMM, Phobius, MEMSAT)

    • Implementation: Weight predictions based on algorithm performance with similar proteins

    • Validation: Compare with experimental topology mapping using reporter fusions

    • Output: Consensus model of transmembrane domain organization

  • Homology modeling with sparse constraints:

    • Approach: Utilize any available structural data from related holins, even with low sequence identity

    • Implementation: Apply distance constraints from crosslinking or mutational studies

    • Validation: Test model predictions with targeted mutagenesis

    • Output: Initial structural models of monomeric holin

  • Coarse-grained membrane simulations:

    • Approach: Simulate holin oligomerization and membrane interactions at longer timescales

    • Implementation: Martini force field or similar coarse-grained approaches

    • Validation: Compare with experimental measurements of oligomerization kinetics

    • Output: Models of holin assembly and membrane deformation

  • Molecular dynamics refinement:

    • Approach: All-atom simulations of key states and transitions

    • Implementation: Focus on critical regions identified in coarse-grained simulations

    • Validation: Compare with experimental measurements of pore formation

    • Output: Detailed mechanisms of conformational changes during triggering

  • Machine learning integration:

    • Approach: Train models on experimental data correlating sequence features with lysis timing

    • Implementation: Use existing datasets on holin variants and their phenotypes

    • Validation: Test predictions with newly designed variants

    • Output: Predictive models for rational holin engineering

These computational approaches should be developed iteratively with experimental validation at each stage. As new structural or functional data becomes available, models should be refined to improve their predictive power for holin engineering applications .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.